What is RUKOBIA?

RUKOBIA is a prescription medicine used in combination with other antiretrovirals (ARVs), indicated to treat HIV-1 infection in adults who:

  • have received several anti-HIV-1 regimens in the past, and
  • have HIV-1 virus that is resistant to many ARV medicines, and
  • are failing their current treatment because the medicines are not working, they are not able to tolerate the side effects, or have other safety concerns

*Based on data from the BRIGHTE trial, where 371 adults received RUKOBIA plus other HIV-1 medicines. All participants who entered the study met the following criteria: virus was detectable while on their current medicines (viral load ≥400 copies/mL), and virus was resistant to many HIV-1 treatments. All participants had limited treatment options left.

†Undetectable means reducing the HIV in your blood to levels below detection.

ASO=AIDS service organization; CBO=community-based organization; HIV-1=human immunodeficiency virus type-1; MDR=multidrug-resistant.

Resources for ASO and CBO professionals

ViiVConnect offers tools, resources, and individual assistance to help your clients get their prescribed ViiV Healthcare medications

Sign up to receive more valuable information about RUKOBIA

Thank you for signing up

PMUS-FSTWCNT240019